publication venue for
- Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease. 18:875-884. 2021
- Current and emerging therapies for coeliac disease. 18:181-195. 2021
- Evidence-based and mechanistic insights into exclusion diets for IBS. 17:406-413. 2020
- First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques. 16:559-579. 2019
- Mechanisms by which gut microorganisms influence food sensitivities. 16:7-18. 2019
- The powerful advantages of extracellular electrical recording. 14:372-372. 2017
- Novel players in coeliac disease pathogenesis: role of the gut microbiota. 12:497-506. 2015
- A role for the gut microbiota in IBS. 11:497-505. 2014
- Intestinal bacteria influence brain activity in healthy humans. 10:326-327. 2013
- Helicobacter pylori infection in functional dyspepsia. 10:168-174. 2013
- The risks of PPI therapy. 9:132-139. 2012
- Can global guidelines change health policy?. 5:120-121. 2008
- Is an evidence-based approach to creating guidelines always the right one?. 5:60-61. 2008
- Are global guidelines desirable, feasible and necessary?. 5:2-3. 2008
- Should triple therapy for Helicobacter pylori eradication be prescribed for 1 week or 2 weeks?. 4:596-597. 2007
- Hamartomatous polyposis syndromes. 4:492-502. 2007
- Peptic ulcer disease today. 3:80-89. 2006
- Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia. 2:70-71. 2005
- Does Helicobacter pylori infection and its eradication have any effect on heartburn and gastroesophageal reflux?. 1:16-17. 2004